Home/Filings/4/0001104659-20-105236
4//SEC Filing

LaBelle Curt H 4

Accession 0001104659-20-105236

CIK 0001682639other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:17 PM ET

Size

14.8 KB

Accession

0001104659-20-105236

Insider Transaction Report

Form 4
Period: 2020-09-11
LaBelle Curt H
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2020-09-11+9,8209,820 total
    Exercise: $3.43Exp: 2030-09-11Common Stock (9,820 underlying)
  • Award

    Common Stock, par value $.0001

    2020-09-11+7,28835,273 total
Holdings
  • Common Stock, par value $.0001

    (indirect: By LLC)
    453,333
  • Stock Option (right to buy)

    Exercise: $1.24From: 2015-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (133,334 underlying)
    133,334
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Stock Option (right to buy)

    Exercise: $3.11Exp: 2029-08-16Common Stock (45,256 underlying)
    45,256
Footnotes (5)
  • [F1]Represents restricted stock units that vest on the earlier of September 11, 2021 or the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The option becomes exercisable on the earlier of September 11, 2021 or the date of the Issuer's 2021 annual meeting at stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon changes in control.
  • [F4]One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  • [F5]The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001396235

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:17 PM ET
Size
14.8 KB